Ceftazidime-avibactam for the treatment of Pseudomonas aeruginosa: a plain language summary
This Plain Language Summary of Publication article (PLSP) from Future Microbiology, describes a global study that tested how well different medicines, including ceftazidime-avibactam (CAZ-AVI), work against Pseudomonas aeruginosa, a type of bacteria that can be difficult to treat when it becomes resistant to multiple drugs. Researchers collected samples from patients worldwide and tested the medicines in the lab to see which ones could stop the bacteria from growing.
Visit the site using this link to read the article.
This PLSP is based on an article called ‘Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020′ and was published in the Journal of Global Antimicrobial Resistance.
Visit Elsevier using the link to read the original article.